Erlotinib and pneumonia 
Erlotinib and pneumonia Patient Reports February 11, 2012
Erlotinib Side Effects Report #5587758-3
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 24, 2007. Male patient, 63 years of age, was diagnosed with tonsil cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: aspiration, dysphagia, hyporeflexia, pneumonia
, radiation dysphagia. Erlotinib dosage: (150 MG). During the same period patient was treated with BEVACIZUMAB, TAXOL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5677828-3
Erlotinib side effect was reported by a Physician from UNITED STATES on Mar 04, 2008. Male patient, 63 years of age, weighting 147.0 lb, was diagnosed with tonsil cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: areflexia, aspiration, bronchial secretion retention, dysphagia, ejection fraction decreased, laryngitis, mucosal inflammation, pneumonia
, saliva altered. Erlotinib dosage: 150 MG. During the same period patient was treated with BEVACIZUMAB, TAXOL, CARBOPLATIN, FLUOROURACIL, LORTAB, PLAVIX, INHALER, KLONOPIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5976474-1
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 14, 2008. Male patient, 78 years of age, weighting 189.6 lb, was diagnosed with renal cell carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood potassium decreased, blood urea increased, nausea
, pneumonia , protein total decreased, rash , scleral hyperaemia, ventricular tachycardia. Erlotinib dosage: (125 MG,QD), ORAL. During the same period patient was treated with ASPIRIN, LIPITOR, LASIX, POTASSIUM CHLORIDE, PLAVIX, TOPROL, FOLIC ACID. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5145304-2
Erlotinib side effect was reported by a Physician from GERMANY on Oct 17, 2006. Female patient, 68 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: c-reactive protein increased, lymphocyte count decreased, neutrophil count decreased, platelet count decreased, pneumonia
, white blood cell count decreased. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, ENOXAPARIN, MACROGOL, METOPROLOL TARTRATE, MORPHINE SULPHATE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6121207-1
Erlotinib side effect was reported by a Physician from ITALY on Feb 27, 2009. Male patient, 66 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, disease progression, interstitial lung disease, lung disorder, lymphangitis, pneumocystis jiroveci infection, pneumonia
. Erlotinib dosage: (100 MG, QD), ORAL. Patient died.Erlotinib Side Effects Report #5385085-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on July 10, 2007. Male patient, 66 years of age, weighting 166.0 lb, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: lung infiltration, oxygen saturation decreased, pneumonia
, procedural complication, pulmonary embolism . Erlotinib dosage: 100MGM EVERY DAY ORAL. Patient died on 06/27/2007.Erlotinib Side Effects Report #4928557-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 08, 2006. Female patient, 65 years of age, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal distension, diarrhoea, dyspnoea, pleural effusion, pneumonia
, pulmonary embolism . Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5262366-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 09, 2007. Male patient, weighting 169.0 lb, was diagnosed with non-small cell lung cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atelectasis, disease progression, obstructive airways disorder, pleural effusion, pneumonia
. Erlotinib dosage: 175MG DAILY PO. During the same period patient was treated with NORVASC, NEXIUM, NOVOLOG, LANTUS, PRANDIN, VYTORIN, AMBIEN, OXYCODONE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6060242-9
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on Jan 14, 2009. Male patient, 78 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, hypotension, lower respiratory tract infection, malignant neoplasm progression, non-small cell lung cancer, pneumonia
. Erlotinib dosage: (150 MG, QD) ,ORAL. Patient was hospitalized. Patient died on 01/01/2009.Erlotinib Side Effects Report #5332840-9
Erlotinib side effect was reported by a Physician from GERMANY on Mar 05, 2007. Male patient, 76 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: infection
, myocardial infarction, pneumonia . Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with CISPLATIN, GEMZAR, BISOPROLOL FUMARATE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5248432-6
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 06, 2007. Male patient, 72 years of age, weighting 171.7 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, haemoglobin decreased, pneumonia
, respiratory distress, respiratory failure. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with PREDNISONE, LISINOPRIL, ATENOLOL. Patient was hospitalized. Patient died on 01/18/2007.Erlotinib Side Effects Report #5320705-8
Erlotinib side effect was reported by a Physician from UNITED STATES on Apr 17, 2007. Male patient, 72 years of age, weighting 171.7 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, disease progression, lung cancer metastatic, pneumonia
, pulmonary fibrosis . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with PREDNISONE, LISINOPRIL, ATENOLOL. Patient was hospitalized. Patient died on 01/18/2007.Erlotinib Side Effects Report #5318467-3
Erlotinib side effect was reported by a Physician from GERMANY on Apr 16, 2007. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pneumonia
, pneumothorax. Erlotinib dosage: 150 MG (QD) ORAL. During the same period patient was treated with MARCUMAR, NEBIVOLOL, ENALAPRIL, ENOXAPARIN, MOXIFLOXACIN, ESIDRIX, POTASSIUM CHLORIDE, TEPILTA. Patient was hospitalized. Patient died on 03/29/2007.Erlotinib Side Effects Report #5599794-1
Erlotinib side effect was reported by a Physician from UNITED STATES on Jan 18, 2008. Female patient, 71 years of age, weighting 145.5 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pneumonia
. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5634460-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 20, 2008. Female patient, 71 years of age, weighting 143.3 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pneumonia
, respiratory failure. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5917595-9
Erlotinib side effect was reported by a Health Professional from CANADA on Sept 26, 2008. Female patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardiac failure, pneumonia
, respiratory distress. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with ATENOLOL, ENALAPRIL MALEATE, FUROSEMIDE, ATORVASTATIN CALCIUM, POTASSIUM AND CLOPODOGREL. Patient died on 09/11/2008.Erlotinib Side Effects Report #5679698-6
Erlotinib side effect was reported by a Physician from JAPAN on Mar 05, 2008. Female patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: delirium, pneumonia
, somnolence, suicidal ideation. Erlotinib dosage: (150 MG, QD), ORAL. Patient recovered.Erlotinib Side Effects Report #5217471-3
Erlotinib side effect was reported by a Health Professional from TAIWAN, PROVINCE OF CHINA on Jan 03, 2007. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bronchiectasis, bronchoscopy abnormal, haemoptysis, lung consolidation, necrosis, pleural effusion, pneumonia
, pneumothorax, pulmonary cavitation. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with METFORMIN, GLIMEPIRIDE, MONTELUKAST, TAMSULOSIN, TRIAMCINOLONE, SENNOSIDE, CLARINASE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5230795-9
Erlotinib side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Jan 26, 2007. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bronchiectasis, diabetes mellitus inadequate control, disease progression, necrosis, pleural effusion, pneumonia
, pneumothorax, subcutaneous emphysema, tuberculosis . Erlotinib dosage: 150 MG QD, ORAL. During the same period patient was treated with METFORMIN, GLIMEPIRIDE, MONTELUKAST, TAMSULOSIN, TRIAMCINOLONE, SENNOSIDE, CLARINASE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5245532-1
Erlotinib side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Feb 02, 2007. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bronchiectasis, bronchoscopy abnormal, disease progression, haemoptysis, lung consolidation, necrosis, pleural effusion, pneumonia
, pneumothorax. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with METFORMIN, GLIMEPIRIDE, MONTELUKAST, TAMSULOSIN, TRIAMCINOLONE, SENNOSIDE, CLARINASE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5954650-1
Erlotinib side effect was reported by a Health Professional from UNITED KINGDOM on Oct 29, 2008. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardiac failure, cardiac failure congestive, cardiomegaly, pneumonia
, rash , stomatitis. Erlotinib dosage: (150 MG), ORAL. During the same period patient was treated with ASPIRIN, AMLODIPINE, LACTULOSE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5229275-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Jan 27, 2007. Male patient, 65 years of age, weighting 197.5 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: interstitial lung disease, lymphadenopathy, pneumonia
, pulmonary oedema, respiratory failure. Erlotinib dosage: 150 MG, QD. During the same period patient was treated with AVASTIN, OXYGEN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5088243-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Aug 10, 2006. Male patient, 65 years of age, weighting 197.5 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: interstitial lung disease, lymphadenopathy, pneumonia
, pulmonary oedema, respiratory failure. Erlotinib dosage: 150 MG, QD. During the same period patient was treated with AVASTIN, OXYGEN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5339619-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 25, 2007. Male patient, 64 years of age, weighting 149.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, pneumonia
. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, HYDROCODONE, IMODIUM, PROCHLORPERAZINE MALEATE, MEGACE. Patient died on 04/20/2007.Erlotinib Side Effects Report #5869425-1
Erlotinib side effect was reported by a Health Professional from SWITZERLAND on Aug 13, 2008. Female patient, 62 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cough, pleural effusion, pneumonia
, pyrexia, rhinitis. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5900777-X
Erlotinib side effect was reported by a Health Professional from SWITZERLAND on Sept 12, 2008. Female patient, 62 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pleural effusion, pneumonia
, rhinitis. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5925694-0
Erlotinib side effect was reported by a Physician from SWITZERLAND on Oct 03, 2008. Female patient, 62 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: malaise, pleural effusion, pneumonia
, rhinitis. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5956030-1
Erlotinib side effect was reported by a Physician from SWITZERLAND on Oct 27, 2008. Female patient, 56 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: catheter sepsis, cholelithiasis, enterococcal sepsis, gastric neoplasm, gastrointestinal haemorrhage, pancreatitis acute, pneumonia
. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB, GEMZAR, CARBOPLATIN, AUGMENTIN, CLARITHROMYCIN, CEFEPIME, VANCOMYCIN, METHOTREXATE. Patient was hospitalized. Patient died on 09/21/2008.Erlotinib Side Effects Report #5984665-9
Erlotinib side effect was reported by a Physician from SWITZERLAND on Nov 18, 2008. Female patient, 56 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: catheter sepsis, cholelithiasis, enterococcal sepsis, gastric neoplasm, gastrointestinal haemorrhage, malignant neoplasm progression, pancreatitis acute, pneumonia
. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB, GEMZAR, CARBOPLATIN, AUGMENTIN, CLARITHROMYCIN, CEFEPIME, VANCOMYCIN, METHOTREXATE. Patient was hospitalized. Patient died on 09/21/2008.Erlotinib Side Effects Report #5786021-5
Erlotinib side effect was reported by a Physician from GERMANY on June 05, 2008. Male patient, 55 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pneumonia
, refusal of treatment by patient. Erlotinib dosage: unknown. During the same period patient was treated with FLUORODEOXGLUCOSE F, FLUOROTHYMIDINE F, NOVAMINUSFLON, BELOC, NEXIUM. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5803923-1
Erlotinib side effect was reported by a Physician from GERMANY on June 18, 2008. Male patient, 55 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pneumonia
. Erlotinib dosage: unknown. During the same period patient was treated with FLUORODEOXYGLUCOSE F, FLUOROTHYMIDINE F, NOVAMINSULFON, BELOC, NEXIUM. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5822140-2
Erlotinib side effect was reported by a Physician from GERMANY on July 09, 2008. Male patient, 55 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood lactate dehydrogenase increased, interstitial lung disease, lymphocyte percentage decreased, pneumonia
. Erlotinib dosage: unknown. During the same period patient was treated with FLUORODEOXYGLUCOSE F, FLUOROTHYMIDINE F, NOVAMINSULFON, BELOC, NEXIUM, NOVALGIN, ZOMETA. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5976548-5
Erlotinib side effect was reported by a Physician from KOREA, REPUBLIC OF on Nov 11, 2008. Male patient, 54 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pneumonia
. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with GABAPENTIN, MAGNESIUM OXIDE. Patient died on 05/15/2008.Erlotinib Side Effects Report #5506949-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 18, 2007. Male patient, 52 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood albumin decreased, blood alkaline phosphatase increased, condition aggravated, dehydration, diarrhoea, lung cancer metastatic, pneumonia
. Erlotinib dosage: 150 MG, QD, ORAL. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5739357-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 29, 2008. Male patient, 52 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood albumin decreased, blood alkaline phosphatase increased, dehydration, diarrhoea, metastases to lung, pneumonia
, pyrexia. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with HYDROCODONE, ACETAMINOPHEN, DIPHENHYDRAMINE, CEPHALEXIN, IBUPROFEN, LOPERAMIDE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5643861-0
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 12, 2008. Female patient, 47 years of age, weighting 183.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atelectasis, effusion, lung consolidation, nausea
, pneumonia . Erlotinib dosage: (150 MG, QD), ORAL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5301236-8
Erlotinib side effect was reported by a Physician from KOREA, REPUBLIC OF on Mar 26, 2007. Female patient, 43 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pneumonia
. Erlotinib dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5307352-9
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 20, 2007. Male patient, weighting 149.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, pneumonia
. Erlotinib dosage: 150 MG, QD. During the same period patient was treated with AVASTIN, HYDROCODONE, IMODIUM, PROCHLORPERAZINE, MEGACE. Patient died on 04/20/2007.Erlotinib Side Effects Report #5308406-3
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 20, 2007. Male patient, weighting 151.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pleural effusion, pneumonia
. Erlotinib dosage: unknown. Patient recovered.Erlotinib Side Effects Report #5315904-5
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 25, 2007. Male patient, weighting 149.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pneumonia
. Erlotinib dosage: 150 MG, QD. During the same period patient was treated with AVASTIN, HYDROCODONE, IMODIUM, PROCHLORPERAZINE, MEGACE. Patient died on 04/20/2007.Erlotinib Side Effects Report #5758376-9
Erlotinib side effect was reported by a Health Professional from UNITED STATES on June 02, 2008. Female patient, weighting 124.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pneumonia
. Erlotinib dosage: 150MG PO QD. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5383679-X
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 30, 2007. Female patient, 63 years of age, weighting 106.0 lb, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, large intestine perforation, neutropenia, peridiverticular abscess, platelet count decreased, pneumonia
. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, DURAGESIC, OXYCODONE, AMBIEN CR, DECADRON, COMPAZINE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5875064-9
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 08, 2008. Female patient, 59 years of age, was diagnosed with lung cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, faeces discoloured, fatigue, gastrointestinal haemorrhage, hypoxia, lung disorder, pneumonia
. Erlotinib dosage: 150 MG ORAL ONCE DAILY. Patient died on 09/03/2008.Erlotinib Side Effects Report #5890310-3
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 05, 2008. Female patient, 59 years of age, was diagnosed with lung cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, fatigue, gastrointestinal haemorrhage, hypoxia, pneumonia
. Erlotinib dosage: 150 MG,QD, ORAL. Patient was hospitalized. Patient died on 09/03/2008.Erlotinib Side Effects Report #5832820-0
Erlotinib side effect was reported by a Physician from JAPAN on July 17, 2008. Male patient, 89 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: interstitial lung disease, pleural effusion, pneumonia
. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with NAUZELIN, MEDICON, SELBEX, OMEPRAZOLE. Patient died.Erlotinib Side Effects Report #6062838-7
Erlotinib side effect was reported by a Physician from JAPAN on Jan 16, 2009. Male patient, 75 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: emphysema, folliculitis, obstructive airways disorder, paralysis
, periproctitis, pneumonia , pyelonephritis, respiratory failure, skin ulcer. Erlotinib dosage: 150 MG, QD, ORAL, 100 MG. During the same period patient was treated with SUCRALFATE, ETODOLAC, MUCOSTA, LASIX, OXYCONTIN, JUZENTA IHOTO. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5936212-5
Erlotinib side effect was reported by a Health Professional from JAPAN on Oct 13, 2008. Female patient, 68 years of age, weighting 130.1 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: henoch-schonlein purpura, hyperbilirubinaemia, paronychia, pneumonia
, rash . Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with LENODORMIN, ALOSENN, MAGNESIUM OXIDE, DIOVAN, LOXONIN, RHYTHMY, GASTER D, ACTONEL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5839450-5
Erlotinib side effect was reported by a Physician from JAPAN on July 24, 2008. Male patient, 55 years of age, weighting 136.7 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: activities of daily living impaired, chronic obstructive pulmonary disease, hypophagia, lung neoplasm malignant, malignant neoplasm progression, metastases to adrenals, metastases to lung, pneumonia
, pulmonary embolism . Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with VOLTAREN, LANSOPRAZOLE, BEZATROL, PRIMPERAN, NOVAMIN, OXYCONTIN. Patient was hospitalized. Patient died on 05/05/2008.Erlotinib Side Effects Report #5529685-3
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Nov 12, 2007. Female patient, 44 years of age, was diagnosed with colon cancer metastatic, breast cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, constipation
, dehydration, haemoglobin decreased, lethargy, nausea , platelet count decreased, pneumonia . Erlotinib dosage: 75 MG, QD, ORAL. During the same period patient was treated with VINFLUNINE, FENTANYL PATCH, OXYCODONE, KYTRIL, PROMETHAZINE, LEVSIN, MORPHINE, DIAZEPAM. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6094376-X
Erlotinib side effect was reported by a Health Professional from JAPAN on Feb 10, 2009. Male patient, 63 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: hypoxia, metastases to pleura, pneumonia
. Erlotinib dosage: (150 MG, QD), ORAL. Patient was hospitalized. Patient recovered.